Ungrodt Jodi reported option exercise involving 5,647 shares of BioStem Technologies, Inc. at $0.00 for $0 on Aug 27, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Aug 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
5,647Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
11,295Direct
Trade date
Aug 27, 2026Option exercise
Filed
Aug 28, 2026, 4:15 PM ET1-day reporting delay
Accession
0002147392-26-000005Code M · Transaction 117384
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 27, 2026Option exercise5,647$0.00$0Trade 117385
2 transaction rows in this filing. Joint filers share the same rows.

BSEM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BSEM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago +4.2%1d ago +3.7%
Returns since7d +5.1%30d +17%90d180d1y

Footnotes in full

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2: These restricted stock units vest in two installments. The first installment vested on May 27, 2026, and the remaining installment vested on August 27, 2026.